LTR for Obstructive Sleep Apnea
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called the LinguaFlex™ Tongue Retractor (LTR) to determine its effectiveness in reducing Obstructive Sleep Apnea and snoring. The LTR is placed in the tongue to prevent it from sliding back and blocking the airway during sleep. The trial will last one year and aims to evaluate the LTR's effectiveness in keeping airways open. Individuals with moderate to severe sleep apnea, confirmed by a recent sleep study, might be suitable candidates for this study. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance sleep apnea treatment options.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, you must agree not to use any additional therapy for sleep apnea during the study.
What prior data suggests that the LinguaFlex Tongue Retractor is safe for treating obstructive sleep apnea?
Research shows that the LinguaFlex™ Tongue Retractor (LTR) is being tested to help with obstructive sleep apnea by keeping the airway open during sleep. Previous users found the device generally easy to tolerate. No reports of serious side effects have emerged from its use. Some minor side effects, such as discomfort or irritation at the placement site, might occur, but these are temporary and manageable. Overall, evidence suggests that the LTR is safe for use, with careful monitoring throughout the study.12345
Why are researchers excited about this trial?
The LinguaFlex Tongue Retractor (LTR) is unique because it offers a non-invasive approach to treating obstructive sleep apnea by physically repositioning the tongue to keep airways open during sleep. Unlike current standard treatments like CPAP machines, which require wearing a face mask, or surgeries that can be invasive, the LTR device is inserted into the tongue for a more discreet and less intrusive solution. Researchers are excited about LTR because it has the potential to improve comfort and adherence for patients who struggle with existing therapies, leading to better management of sleep apnea symptoms over time.
What evidence suggests that the LinguaFlex Tongue Retractor is effective for Obstructive Sleep Apnea?
Research has shown that the LinguaFlex™ Tongue Retractor (LTR), which participants in this trial will receive, can help reduce obstructive sleep apnea and snoring. One study found that the device is safe, effective, and well-received by patients. Notably, the LTR's effectiveness does not depend on the severity of a person's sleep apnea or their body mass index (BMI). The device prevents the tongue from moving backward during sleep, keeping the airway open. This reduces the blockage or narrowing of the airway that causes apnea and snoring. Overall, initial results are promising for those considering this treatment.678910
Who Is on the Research Team?
Ira Sanders, MD
Principal Investigator
Linguaflex, Inc.
Are You a Good Fit for This Trial?
Adults over 18 with moderate to severe Obstructive Sleep Apnea (OSA) who have an AHI score of 15-50 and haven't found success with PAP therapy can join. They must not use other OSA treatments during the study, be able to consent, and not be pregnant or have certain medical conditions like heart failure or bleeding disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the LinguaFlex Tongue Retractor device and are monitored over the course of 1 year
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of sleepiness, pain, speech, swallowing, and snoring
What Are the Treatments Tested in This Trial?
Interventions
- LinguaFlex Tongue Retractor (LTR)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Linguaflex, Inc.
Lead Sponsor